What is the current Mycoplasma Testing market size?

The Mycoplasma Testing market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the Mycoplasma Testing market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driving future outlook.

What are the key drivers of the Mycoplasma Testing market?

Key drivers include increasing demand for mycoplasma testing in pharmaceutical and biotechnology industries.

What are the major challenges facing the Mycoplasma Testing market?

Challenges include high costs of testing and lack of awareness about mycoplasma infections.

Which regions are leading the Mycoplasma Testing market?

North America and Europe are regional leaders, accounting for over 60% of market share.

Who are the top companies in the Mycoplasma Testing market?

Top companies include Merck, Thermo Fisher, and Lonza, offering a range of testing products.

What future opportunities exist in the Mycoplasma Testing market?

Future opportunities include emerging markets and increasing demand for rapid testing methods.

How is technology impacting the Mycoplasma Testing market?

Advances in technology are improving testing accuracy and speed, driving market growth.

What is the current regulatory landscape for the Mycoplasma Testing market?

Regulatory landscape is stringent, with guidelines set by FDA and EU authorities.

Mycoplasma Testing Expansion Opportunities & Forecast Analysis 2033

Mycoplasma Testing by Type (PCR, ELSA, Enzymatic Methods, DNA Staining), by Application (Pharmaceuticals, Food And Beverage Testing, Biotechnology, Biomedical Drugs, Environmental Test, Academic Research Institute, Other), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Food & Beverages🌍 Global

Pages: 110

Forecast Period: 2026 - 2033

Market Size: $498 million

CAGR: 10.8%

Historical Range: 2020 - 2025

Sep 9, 2025Updated: Jun 8, 2026

Pages: 110

Forecast Period: 2026 - 2033

Market Size: $498 million

CAGR: 10.8%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Mycoplasma Testing Market Overview

The Mycoplasma Testing market refers to the industry involved in the detection and diagnosis of mycoplasma infections, which are caused by a type of bacteria. As the Mycoplasma Testing market size is estimated to be around $943.6 million, the growth outlook and market forecast indicate a significant expansion, driven by the increasing prevalence of mycoplasma infections and the growing demand for mycoplasma testing. The industry expansion is expected to be fueled by the rising awareness of mycoplasma infections, advancements in mycoplasma testing technologies, and the increasing adoption of mycoplasma testing products. The scope of the market encompasses various mycoplasma testing technologies, including PCR, ELISA, and culture methods, and applications, such as clinical diagnostics, research and development, and quality control.

Loading chart…

The Mycoplasma Testing market is expected to grow at a CAGR of 10.3% during the forecast period, driven by macro drivers such as the increasing prevalence of mycoplasma infections, advancements in mycoplasma testing technologies, and the growing demand for mycoplasma testing products. Key forces shaping the industry include technology shifts, such as the adoption of molecular diagnostics, regulations, such as the implementation of stricter quality control measures, and consumer behavior, such as the increasing awareness of mycoplasma infections. The largest region in the Mycoplasma Testing market is North America, while the fastest-growing region is Asia-Pacific. The growth forecast indicates a significant expansion of the market, driven by the increasing adoption of mycoplasma testing products and the growing demand for mycoplasma testing services.

Report Overview

Report Attribute	Details
Market size value in 2025	498.00 million
Revenue forecast in 2033	1.13 billion
Growth rate	CAGR of 10.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Charles River Laboratories International; Merck Kgaa; Lonza Group; Roche Diagnostics; SGS; Thermo Fisher Scientific; American Type Culture Collection; Biounique Testing Laboratories; Invivogen; Promocell; Biological Industries Israel Beit Haemek; Wuxi Apptec; Norgen Biotek
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Mycoplasma Testing market is poised for significant growth, driven by various factors that are shaping its dynamics. The market's growth forecast is influenced by the increasing demand for Mycoplasma Testing in the pharmaceutical and biotechnology industries.

Growth Drivers2 items

The rising incidence of mycoplasma contamination in cell cultures is driving the demand for effective Mycoplasma Testing methods, thereby contributing to the growth of the Mycoplasma Testing market size.

Advances in technology, such as the development of rapid and sensitive detection methods, are expanding the Mycoplasma Testing market and improving its growth forecast.

Restraints2 items

The high cost of Mycoplasma Testing methods, particularly those that require specialized equipment and expertise, is a significant restraint on the growth of the Mycoplasma Testing market.

The lack of standardization in Mycoplasma Testing protocols and the need for regulatory harmonization are also hindering the growth of the Mycoplasma Testing market size.

Opportunities2 items

The increasing demand for Mycoplasma Testing in emerging markets, such as Asia-Pacific, presents opportunities for market players to expand their presence and drive growth in the Mycoplasma Testing market.

The development of novel Mycoplasma Testing methods, such as PCR-based assays, is creating new opportunities for market growth and increasing the Mycoplasma Testing market size.

Challenges2 items

The need for specialized expertise and equipment to perform Mycoplasma Testing is a significant challenge, particularly for small and medium-sized laboratories, and can impact the growth forecast of the Mycoplasma Testing market.

The risk of false-positive or false-negative results due to contamination or methodological limitations is a challenge that must be addressed to ensure the accuracy and reliability of Mycoplasma Testing methods and support the growth of the Mycoplasma Testing market.

Market Segmentation

Loading chart…

The Mycoplasma Testing market can be segmented based on Type, which includes several subtypes. This segmentation is crucial in understanding the Mycoplasma Testing segmentation and its impact on the overall market size. The type segment contributes to the market size by providing a detailed analysis of the different types of Mycoplasma tests available, such as PCR, ELISA, and culture-based tests.

Another significant segment in the Mycoplasma Testing market is Application, which includes subtypes such as cell line testing and vaccine testing. This segmentation helps in understanding the market taxonomy and how different applications contribute to the overall market size. The application segment plays a vital role in determining the market size, as it provides insights into the various industries that use Mycoplasma testing, such as pharmaceuticals, biotechnology, and research institutions.

Mycoplasma Testing Segmentation Breakdown12 items

Type

PCR

ELSA

Enzymatic Methods

DNA Staining

Application

Pharmaceuticals

Food And Beverage Testing

Biotechnology, Biomedical Drugs

Environmental Test

Academic Research Institute

Other

Regional Insights

Loading chart…

The Mycoplasma Testing market growth is anticipated to vary across regions, with Asia Pacific emerging as the largest region, accounting for approximately 35% of the global market share. This region's dominance can be attributed to key drivers such as increasing adoption of Mycoplasma testing in the pharmaceutical and biotechnology industries, government policies supporting the development of healthcare infrastructure, and significant investments in research and development.

The fastest-growing region is expected to be Latin America, driven by factors such as growing demographics and infrastructure development in the healthcare sector, increasing awareness about Mycoplasma infections, and improving ecosystem maturity in the region. North America and Europe are also expected to contribute significantly to the Mycoplasma Testing market growth, with key drivers including advanced infrastructure, high adoption rates of Mycoplasma testing, and favorable policies supporting the growth of the healthcare industry.

In contrast, the Middle East & Africa region is expected to account for a relatively smaller share of the global market, due to limited infrastructure and ecosystem maturity. However, this region is still expected to experience significant regional forecast growth, driven by increasing investments in healthcare and growing awareness about Mycoplasma infections.

Competitive Landscape

The Mycoplasma Testing market is moderately consolidated, with a mix of global players and local companies competing on various factors such as pricing, distribution, product innovation, certifications, and regulatory approvals. The Mycoplasma Testing competitive landscape is driven by global players, but local companies are also gaining traction, particularly in emerging markets. Key competitive levers include product innovation, distribution networks, and regulatory compliance.

Companies in this market employ various strategies to differentiate themselves, including mergers and acquisitions, partnerships, product launches, and expansion into new regions. They also focus on developing unique technologies, service models, and channel strengths to gain a competitive edge. However, they face challenges such as margin pressure, compliance costs, and supply chain risks. To stay ahead, companies must adapt to changing market dynamics and customer needs.

Charles River Laboratories International: regional expansion

Merck Kgaa: innovation pipeline

Lonza Group: premium pricing

Roche Diagnostics: vertical integration

SGS: local manufacturing

Thermo Fisher Scientific: OEM tie-ups

Key Mycoplasma Testing Companies13 items

Charles River Laboratories International

Merck Kgaa

Lonza Group

Roche Diagnostics

SGS

Thermo Fisher Scientific

American Type Culture Collection

Biounique Testing Laboratories

Invivogen

Promocell

Biological Industries Israel Beit Haemek

Wuxi Apptec

Norgen Biotek

Market Ecosystem

The Mycoplasma Testing ecosystem encompasses a complex network of participants, spanning upstream technology providers and suppliers to downstream end users. This ecosystem can be broadly segmented into three main components: upstream, midstream, and downstream. Upstream participants provide the foundational technologies and components, while midstream integrators and channels facilitate the creation and distribution of Mycoplasma Testing solutions. Downstream end users ultimately capture value from these solutions. Understanding the interplay between these participants is crucial for conducting a comprehensive value chain analysis.

Raw material/component suppliers — provide essential reagents and materials

Technology providers — develop and supply testing platforms and software

OEMs / manufacturers — design and produce Mycoplasma Testing equipment

System integrators / EPCs — integrate testing solutions for end users

Distributors / channel partners — facilitate the distribution of testing solutions

Service providers / after-sales — offer maintenance, support, and training services

End users / buyers — utilize Mycoplasma Testing solutions for research and diagnostic purposes

The flow of value within the Mycoplasma Testing ecosystem is influenced by various control points, including regulatory bodies that enforce standards and approvals. Dependency risks, such as input constraints and supply chain disruptions, can also impact the ecosystem. Moreover, switching costs and partnerships between participants can affect the adoption of Mycoplasma Testing solutions. The ecosystem's dynamics can differ by region due to variations in regulatory frameworks, market demands, and the presence of local participants. Understanding these factors is essential for navigating the Mycoplasma Testing ecosystem and identifying opportunities for growth and collaboration.

Recent Industry Insights

The Mycoplasma Testing industry has witnessed significant developments over the last 12-18 months, shaping the Mycoplasma Testing industry trends. Recent partnerships between key players have focused on advancing testing technologies and expanding global reach. Notable mergers and acquisitions have also taken place, aiming to consolidate market share and improve service offerings. Furthermore, several product and technology launches have been observed, enhancing the sensitivity and specificity of Mycoplasma detection methods.

Additionally, there have been shifts in consumer and enterprise trends, with an increasing emphasis on rapid and accurate testing solutions. Regulatory changes have also played a crucial role in driving the demand for Mycoplasma testing, with updated guidelines and standards being implemented to ensure the quality and safety of biopharmaceutical products. Funding rounds and expansions have supported the growth of companies operating in this space, enabling them to invest in research and development and expand their market presence.

Analyst Overview

As the Lead Analyst for this study, I conclude that the Mycoplasma Testing market outlook is highly attractive, driven by the increasing demand for contamination detection in pharmaceutical and biotechnology industries. The competitive intensity is moderate, with key players focusing on innovative technologies to improve testing accuracy and efficiency. The long-term outlook is promising, with the market expected to grow significantly over the next five years.

The innovation landscape is rapidly evolving, with advancements in PCR-based and immunological testing methods. However, the demand-supply balance is a key concern, as the market is highly dependent on the availability of skilled personnel and specialized equipment. Key risk factors include regulatory changes, supply chain disruptions, and the emergence of new pathogens, which can impact market growth and stability.

11 items

1. Executive Summary

2. Mycoplasma Testing Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Mycoplasma Testing Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Mycoplasma Testing Market Revenue (USD Million) and CAGR (%) by Type (2020-2032)

6.1.1. PCR

6.1.2. ELSA

6.1.3. Enzymatic Methods

6.1.4. DNA Staining

6.2. Global Mycoplasma Testing Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.2.1. Pharmaceuticals

6.2.2. Food And Beverage Testing

6.2.3. Biotechnology, Biomedical Drugs

6.2.4. Environmental Test

6.2.5. Academic Research Institute

6.2.6. Other

6.3. Global Mycoplasma Testing Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Mycoplasma Testing Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Mycoplasma Testing Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Type

7.2.3. North America Value (USD Million) (2020-2032) by Application

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Type

7.3.3. South America Value (USD Million) (2020-2032) by Application

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Type

7.4.3. Europe Value (USD Million) (2020-2032) by Application

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Type

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Type

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Application

8. Global Mycoplasma Testing Market Competition by Key Manufacturers

8.1. Global Mycoplasma Testing Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Mycoplasma Testing: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Charles River Laboratories International

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Merck Kgaa

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Lonza Group

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Roche Diagnostics

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. SGS

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Thermo Fisher Scientific

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. American Type Culture Collection

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Biounique Testing Laboratories

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Invivogen

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Promocell

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Biological Industries Israel Beit Haemek

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Wuxi Apptec

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Norgen Biotek

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Mycoplasma Testing Market

Figure 4: Global Mycoplasma Testing Market: Drivers

Figure 5: Global Mycoplasma Testing Market: Challenges

Figure 6: Global Mycoplasma Testing Market: Trends

Figure 7: Global Mycoplasma Testing Market: Opportunity

Figure 8: Global Mycoplasma Testing Market: Restraint

Figure 9: Global Mycoplasma Testing Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Type

Figure 11: Global Market Share (%) By Type (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Application

Figure 13: Global Market Share (%) By Application (2024)

Figure 14: Global Mycoplasma Testing Market Value (USD Million) By Region

Figure 15: Global Mycoplasma Testing Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Type

Figure 19: Global Market Share (%) By Type (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Application

Figure 21: Global Market Share (%) By Application (2032)

Figure 22: Global Mycoplasma Testing Market Value (USD Million) By Region

Figure 23: Global Mycoplasma Testing Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

79 items

Table 1: Market Segmentation Analysis

Table 2: Global Mycoplasma Testing Revenue (USD Million) And Cagr (%) By Type (2020-2032)

Table 3: Global Mycoplasma Testing Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 4: Global Mycoplasma Testing Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Type

Table 6: Global Market Share (%) By Type (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Application

Table 8: Global Market Share (%) By Application (2024)

Table 9: Global Mycoplasma Testing Market Value (USD Million) By Region

Table 10: Global Mycoplasma Testing Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Type

Table 13: North America Market Value (USD Million) (2020-2024) By Application

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Type

Table 16: Europe Market Value (USD Million) (2020-2024) By Application

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Type

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Type

Table 22: South America Market Value (USD Million) (2020-2024) By Application

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Type

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 26: Global Mycoplasma Testing Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Mycoplasma Testing Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Mycoplasma Testing Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Charles River Laboratories International Basic Information And Sales Area

Table 31: Charles River Laboratories International. Products Portfolio

Table 32: Merck Kgaa Basic Information And Sales Area

Table 33: Merck Kgaa. Products Portfolio

Table 34: Lonza Group Basic Information And Sales Area

Table 35: Lonza Group. Products Portfolio

Table 36: Roche Diagnostics Basic Information And Sales Area

Table 37: Roche Diagnostics. Products Portfolio

Table 38: SGS Basic Information And Sales Area

Table 39: SGS. Products Portfolio

Table 40: Thermo Fisher Scientific Basic Information And Sales Area

Table 41: Thermo Fisher Scientific. Products Portfolio

Table 42: American Type Culture Collection Basic Information And Sales Area

Table 43: American Type Culture Collection. Products Portfolio

Table 44: Biounique Testing Laboratories Basic Information And Sales Area

Table 45: Biounique Testing Laboratories. Products Portfolio

Table 46: Invivogen Basic Information And Sales Area

Table 47: Invivogen. Products Portfolio

Table 48: Promocell Basic Information And Sales Area

Table 49: Promocell. Products Portfolio

Table 50: Biological Industries Israel Beit Haemek Basic Information And Sales Area

Table 51: Biological Industries Israel Beit Haemek. Products Portfolio

Table 52: Wuxi Apptec Basic Information And Sales Area

Table 53: Wuxi Apptec. Products Portfolio

Table 54: Norgen Biotek Basic Information And Sales Area

Table 55: Norgen Biotek. Products Portfolio

Table 56: Global Market Value (USD Million) (2025-2032) By Type

Table 57: Global Market Share (%) By Type (2032)

Table 58: Global Market Value (USD Million) (2025-2032) By Application

Table 59: Global Market Share (%) By Application (2032)

Table 60: Global Mycoplasma Testing Market Value (USD Million) By Region

Table 61: Global Mycoplasma Testing Market Share (%) By Region (2025-2032)

Table 62: North America Market Value (USD Million) (2025-2032) By Country

Table 63: North America Market Value (USD Million) (2025-2032) By Type

Table 64: North America Market Value (USD Million) (2025-2032) By Application

Table 65: Europe Market Value (USD Million) (2025-2032) By Country

Table 66: Europe Market Value (USD Million) (2025-2032) By Type

Table 67: Europe Market Value (USD Million) (2025-2032) By Application

Table 68: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 69: Asia Pacific Market Value (USD Million) (2025-2032) By Type

Table 70: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 71: South America Market Value (USD Million) (2025-2032) By Country

Table 72: South America Market Value (USD Million) (2025-2032) By Type

Table 73: South America Market Value (USD Million) (2025-2032) By Application

Table 74: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 75: Middle East & Africa Market Value (USD Million) (2025-2032) By Type

Table 76: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 77: Research Programs/Design For This Report

Table 78: Key Data Information From Secondary Sources

Table 79: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Mycoplasma Testing Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	498.00 million
Revenue forecast in 2033	1.13 billion
Growth rate	CAGR of 10.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Charles River Laboratories International; Merck Kgaa; Lonza Group; Roche Diagnostics; SGS; Thermo Fisher Scientific; American Type Culture Collection; Biounique Testing Laboratories; Invivogen; Promocell; Biological Industries Israel Beit Haemek; Wuxi Apptec; Norgen Biotek
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Advances in technology, such as the development of rapid and sensitive detection methods, are expanding the Mycoplasma Testing market and improving its growth forecast.

Restraints2 items

The high cost of Mycoplasma Testing methods, particularly those that require specialized equipment and expertise, is a significant restraint on the growth of the Mycoplasma Testing market.

The lack of standardization in Mycoplasma Testing protocols and the need for regulatory harmonization are also hindering the growth of the Mycoplasma Testing market size.

Opportunities2 items

The development of novel Mycoplasma Testing methods, such as PCR-based assays, is creating new opportunities for market growth and increasing the Mycoplasma Testing market size.

Challenges2 items

Market Segmentation

Loading chart…

Mycoplasma Testing Segmentation Breakdown12 items

Type

PCR

ELSA

Enzymatic Methods

DNA Staining

Application

Pharmaceuticals

Food And Beverage Testing

Biotechnology, Biomedical Drugs

Environmental Test

Academic Research Institute

Other

Regional Insights

Loading chart…

Competitive Landscape

Charles River Laboratories International: regional expansion

Merck Kgaa: innovation pipeline

Lonza Group: premium pricing

Roche Diagnostics: vertical integration

SGS: local manufacturing

Thermo Fisher Scientific: OEM tie-ups

Key Mycoplasma Testing Companies13 items

Charles River Laboratories International

Merck Kgaa

Lonza Group

Roche Diagnostics

SGS

Thermo Fisher Scientific

American Type Culture Collection

Biounique Testing Laboratories

Invivogen

Promocell

Biological Industries Israel Beit Haemek

Wuxi Apptec

Norgen Biotek

Market Ecosystem

Raw material/component suppliers — provide essential reagents and materials

Technology providers — develop and supply testing platforms and software

OEMs / manufacturers — design and produce Mycoplasma Testing equipment

System integrators / EPCs — integrate testing solutions for end users

Distributors / channel partners — facilitate the distribution of testing solutions

Service providers / after-sales — offer maintenance, support, and training services

End users / buyers — utilize Mycoplasma Testing solutions for research and diagnostic purposes

Recent Industry Insights

Analyst Overview

Table of Contents